Uday Khire, Ph.D. MBA, Founder and Chief Executive Officer
Dr. Uday Khire has over fifteen years of experience in medicinal chemistry/ drug discovery. After receiving his Ph.D. from National Chemical Laboratory, India, he carried out post-doctoral studies with Prof. H.C. Brown and Prof. Scott D. Rychnovsky. Uday, then joined the Bayer Research Center in West Haven, CT in 1997 and since then has worked on numerous preclinical drug discovery projects in the therapeutic areas of diabetes, obesity and in particular oncology. Uday is a co-inventor of a novel multi-kinase inhibitor, developed jointly by Bayer and Onyx and is approved as first line therapy for kidney and liver cancer in US and other major markets. Uday has authored numerous peer-reviewed international scientific publications and is inventor of many patents/patent applications. Uday received his MBA in pharmaceutical management from Fairleigh Dickinson University, New Jersey.